1. South Korea Stocks

  2. •

    Health technology

  3. •

    Biotechnology
CytoGen, Inc.

CytoGen, Inc.

KKRX:217330
2,505.00
KRW
-140.00
(-5.29%)
-456.55EPS
72.85BMarket Cap

Latest Stock Split

Sep 28, 2022

3:1

For every share held, investors received 3. The price per share adjusted from $57800.00 to $19266.67.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data
Stock Splits APIChatGPT

Stock Split History

  1. Sep 28, 2022
    Before$57800.00
    Split ratio3:1
    After$19266.67
    Forward

About CytoGen, Inc. stock splits

CytoGen, Inc. (KRX:217330) operates in the Biotechnology industry.

CytoGen, Inc. company overview

When did CytoGen, Inc. stock split?

CytoGen, Inc.'s most recent stock split was on September 28, 2022. It was a 3-for-1 forward split, so shareholders received 3 shares for every share they held.

How many times has CytoGen, Inc. stock split?

CytoGen, Inc. has split its stock once. This history records one forward split, on September 28, 2022.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In CytoGen, Inc.'s 3-for-1 split on September 28, 2022, every share became 3 shares.

Will CytoGen, Inc. split its stock again?

CytoGen, Inc. has not announced a new split in our records. Its most recent split was on September 28, 2022, 4 years ago. Companies announce splits in advance, and any new KRX:217330 split will appear on this page.